The terms of the settlement also include a court-imposed five-year probation, during which Orthofix must comply with the terms of a Corporate Integrity Agreement, according to the release.
The charges were brought against the orthopedic device manufacturer in the first quarter of 2011, and executives said they are pleased with the resolution to Orthofix’s third major government investigation settlement this year, according to the release.
More Articles on Coding, Billing and Collections:
16 Spine Devices Receive FDA 510(k) Clearance in November
Morton Hospital Purchases Robotic Orthopedic Surgery System
Max Reinhardt Named Worldwide President of DePuy Synthes Spine
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.